SMARCB1 and nonpapillary renal cell carcinoma: Upregulated and downregulated signatures derived from our RNA-seq data were also significantly positively and negatively enriched, respectively, in the SMARCB1 mutant ccRCC cell lines in the CCLE dataset, suggesting that a similar mechanism accounts for the PAX8 inhibition insensitivity in these models (Figure 4F).